Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021
DUBLIN, Ireland, June 03, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
Year: 2021
Equillium to Host Conference Call Following Presentation of Data from the EQUATE Study in Acute Graft Versus Host Disease at the EHA2021 Virtual Congress of the European Hematology Association on June 11
Presentation and conference call will include topline data from all cohorts The risk-benefit profile observed supports advancing development of itolizumab...
Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer
Development of novel Camsirubicin analog expands Monopar’s therapeutic pipelineWILMETTE, Ill., June 03, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a...
Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing
Proceeds will support development of antibody drugs and discovery platform targeting pro-tumorigenic factors produced by fibroblasts in the tumor microenvironment,...
Oyster Point Pharma Announces Preclinical Study Results and Pipeline Expansion with Enriched Tear Film (ETF™) Gene Therapy to Target Ocular Surface Diseases
Introduction of proprietary ETF™ Gene Therapy and first gene candidate, nerve growth factor (NGF), to target Stages 2 and 3...
Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"),...
Krystal Biotech to Participate in Upcoming Investor Conferences
PITTSBURGH, June 03, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for...
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
Cambridge, MA, June 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) invites our shareholders and other interested parties...
SR Scales Adds New Utility Cart to Product Line
SRC-600 Can Be Used as Stand-Alone or Accessory Cart to SR’s Pediatric ScalesTONAWANDA, N.Y., June 03, 2021 (GLOBE NEWSWIRE) --...
PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference
CRANBURY, N.J., June 03, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Cynata signs Licence Agreement with TekCyte to advance Clinical Trial in Diabetic Foot Ulcers
MELBOURNE, Australia, June 03, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology...
Onconova Therapeutics Announces Upcoming Presentation at 2021 BIO Digital
NEWTOWN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on...
Histogen Provides Update on its Development Programs and Pipeline Focus
Company to Focus its Regenerative Medicine Technology Platform on Developing Orthopedic Product Candidates HST 003 Trial for Cartilage Regeneration in...
Neuronetics to Present at The JMP Securities Life Sciences Conference
MALVERN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
Rain Therapeutics Announces Collaboration with Tempus for Genomic Analysis in Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32
Clinical trial for MDM2 amplified cancers expected to commence in second half of 2021NEWARK, Calif., June 03, 2021 (GLOBE NEWSWIRE)...
Anika Hosts 2021 Virtual Investor Day
Company details multi-year Joint Preservation strategy for accelerated revenue growth and profitability Updates 2021 directional outlook and 2024 multi-year targets BEDFORD,...
Avicanna Announces Mailing of Management Information Circular and Proposed Board Changes
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...
KemPharm Executives to Participate in Panel Discussions During Upcoming June 2021 Conferences
CELEBRATION, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and...
LifeMD™ Completes $15M Debt Financing
Financing significantly bolsters liquidity position to support continued investment in growth of telehealth businessNEW YORK, June 03, 2021 (GLOBE NEWSWIRE)...
ProMIS Neurosciences Files Preliminary Short Form Base Shelf Prospectus
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR...